Goal 3: Advance Translational Research

Can we leverage exisiting registries to perform prospective trials and advance reduce the cost of doing research?

Current costs for multicenter randomized or non randomized trials are astronomical, and a major obstacle to rapid implementation of potential lifesaving discoveries.

In the field of hematopoietic cell transplantation (HCT) their is a federal mandate to have a treatment outcome registry.

Funds should be made available to leverage that registry to perform prospective trials either randomized or not since HCT programs need to report anyway this could substantially reduce the cost of doing research in this field

Tags (Keywords associated with the idea)


123 net votes
154 up votes
31 down votes
Idea No. 492